Literature DB >> 19521874

Comparison of molecular typing methods applied to Clostridium difficile.

Ed J Kuijper1, Renate J van den Berg, Jon S Brazier.   

Abstract

Since the 1980s the epidemiology of Clostridium difficile infection (CDI) has been investigated by the application of many different typing or fingerprinting methods. To study the epidemiology of CDI, a typing method with a high discriminatory power, typeability, and reproducibility is required. Molecular typing methods are generally regarded as having advantages over phenotypic methods in terms of the stability of genomic markers and providing greater levels of typeability. A growing number of molecular methods have been applied to C. difficile. For the early and rapid detection of outbreak situations, methods such as restriction enzyme analysis, arbitrary primed polymerase chain reaction (PCR), and PCR ribotyping are commonly used. For long-term epidemiology, multilocus sequence typing, multilocus variable number of tandem repeats analysis, and amplified fragment length polymorphism are of interest. Currently, the PCR-ribotyping method and the library of PCR ribotypes in Cardiff are the benchmarks to which most typing studies around the world are compared. Multilocus variable number of tandem repeats analysis is the most discriminative typing method and will contribute significantly to our understanding of the epidemiology of this important nosocomial pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521874     DOI: 10.1007/978-1-60327-999-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.

Authors:  Vladimir Beran; Dittmar Chmelar; Jana Vobejdova; Adela Konigova; Jakub Nemec; Josef Tvrdik
Journal:  Folia Microbiol (Praha)       Date:  2013-10-11       Impact factor: 2.099

2.  Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.

Authors:  V K Viswanathan; M J Mallozzi; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2010-06-16

Review 3.  Diversity and Evolution in the Genome of Clostridium difficile.

Authors:  Daniel R Knight; Briony Elliott; Barbara J Chang; Timothy T Perkins; Thomas V Riley
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 4.  Challenges for standardization of Clostridium difficile typing methods.

Authors:  Charlotte A Huber; Niki F Foster; Thomas V Riley; David L Paterson
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

5.  Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand.

Authors:  Popchai Ngamskulrungroj; Sittinee Sanmee; Papanin Putsathit; Papanin Pusathit; Pipat Piewngam; Briony Elliott; Thomas V Riley; Pattarachai Kiratisin
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

6.  Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation.

Authors:  Hedwig Kurka; Armin Ehrenreich; Wolfgang Ludwig; Marc Monot; Maja Rupnik; Frederic Barbut; Alexander Indra; Bruno Dupuy; Wolfgang Liebl
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

7.  Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.

Authors:  Asiimwe Nicholas; Yu Kyung Kim; Won-Kil Lee; Gati Noble Selasi; Seok Hyeon Na; Hyo Il Kwon; Yoo Jeong Kim; Hae Sook Lee; Kyung Eun Song; Jeong Hwan Shin; Je Chul Lee
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

8.  Evaluation of multiplex PCR with enhanced spore germination for detection of Clostridium difficile from stool samples of the hospitalized patients.

Authors:  Surang Chankhamhaengdecha; Piyapong Hadpanus; Amornrat Aroonnual; Puriya Ngamwongsatit; Darunee Chotiprasitsakul; Piriyaporn Chongtrakool; Tavan Janvilisri
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

9.  How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

Authors:  Ala Szczepura; Susan Manzoor; Katherine Hardy; Nigel Stallard; Helen Parsons; Savita Gossain; Peter M Hawkey
Journal:  BMC Infect Dis       Date:  2014-03-21       Impact factor: 3.090

10.  CRISPR Diversity and Microevolution in Clostridium difficile.

Authors:  Joakim M Andersen; Madelyn Shoup; Cathy Robinson; Robert Britton; Katharina E P Olsen; Rodolphe Barrangou
Journal:  Genome Biol Evol       Date:  2016-09-19       Impact factor: 3.416

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.